Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Geneva hospital reviews 'Magic Mushroom' and LSD therapy for depression

NCT ID NCT07164287

Summary

This study is looking back at medical records to understand how supervised therapy using substances like LSD or psilocybin (from 'magic mushrooms') worked for people with severe depression, anxiety, or addiction. It involves about 376 people in Switzerland who had already received this special treatment because other standard treatments failed. The main goal is to see if the strength of the psychedelic experience is linked to how much their symptoms improved.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Geneva University Hospital

    Geneva, Switzerland

Conditions

Explore the condition pages connected to this study.